Drug Shortage Report for ACT CELECOXIB

Last updated on 2021-02-12 History
Report ID 92232
Drug Identification Number 02420155
Brand name ACT CELECOXIB
Common or Proper name CELECOXIB
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) CELECOXIB
Strength(s) 100MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code M01AH
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2019-08-22
Estimated end date Unknown
Actual end date 2021-02-05
Shortage status Resolved
Updated date 2021-02-12
Company comments Item is Discontinued
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-08-22 English Compare
v2 2019-08-22 French Compare
v3 2019-08-23 English Compare
v4 2019-10-17 English Compare
v5 2019-10-17 French Compare
v6 2019-12-12 English Compare
v7 2019-12-12 French Compare
v8 2020-01-17 English Compare
v9 2020-01-17 French Compare
v10 2020-01-30 English Compare
v11 2020-01-30 French Compare
v12 2020-03-12 English Compare
v13 2020-03-12 English Compare
v14 2020-03-12 French Compare
v15 2020-03-12 English Compare
v16 2020-03-12 French Compare
v17 2021-02-12 English Compare
v18 2021-02-12 French Compare
v19 2021-02-12 French Compare

Showing 1 to 19 of 19